Warning: simplexml_load_string(): Entity: line 29: parser error : Input is not proper UTF-8, indicate encoding ! Bytes: 0xE2 0x80 0x26 0x23 in /mnt/ebs/scidaily/public_html/video.php on line 916 Warning: simplexml_load_string(): e long distances and take time away from work and school to care for their skin, in /mnt/ebs/scidaily/public_html/video.php on line 916 Warning: simplexml_load_string(): ^ in /mnt/ebs/scidaily/public_html/video.php on line 916 Warning: Invalid argument supplied for foreach() in /mnt/ebs/scidaily/public_html/video.php on line 919 Warning: DOMNode::appendChild(): Document Fragment is empty in /mnt/ebs/scidaily/public_html/video.php on line 497 Long Island Hospital May Have Exposed Patients To HIV -- ScienceDaily

Science Videos

from AP, Reuters, AFP, and other news services

Long Island Hospital May Have Exposed Patients To HIV

Date:
March 12, 2014
Source:
Newsy / Powered by NewsLook.com
Summary:
South Nassau Communities Hospital sent out 4,247 letters to patients due to possible blood contamination through reused insulin pen reservoirs. Video provided by Newsy


Related Videos

last updated on 2014-10-30 at 10:48 am EDT

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
Single Dose HIV Drug Launched

Single Dose HIV Drug Launched

AFP (Apr. 8, 2013) — South Africa's health minister launches a new single dose anti-AIDS drug, which reduces the need for HIV positive patients to take multiple pills each day. The country has the largest HIV positive population in the world.
Powered by NewsLook.com
Classes in Hospitals

Classes in Hospitals

Xinhua News Agency (Aug. 31, 2012) — Three years ago, the program "Let's learn at the hospital" began in Veracruz state hospitals in Mexico, such as the High Specialty Regional Hospital of Veracruz and the Regional Hospital "Valentin Gomez Farias" of Coatzacoalcos. The program is for children patients who attend elementary school to receive classes even when they are hospitalized, so that they would not fall behind in their studies.
Powered by NewsLook.com
Finding a Cure Faster: Gay Rights, PhRMA, and a Plague

Finding a Cure Faster: Gay Rights, PhRMA, and a Plague

FORA.tv (May 9, 2013) — Dr Joep Lange has been involved in HIV research and treatment since 1983. He has been the architect and principal investigator of several pivotal trials on antiretroviral therapy and on the prevention of mother-to-child transmission of HIV in both the developed and developing world. In addition to various positions at the AMC, he was Chief of Clinical Research and Drug Development at the Global program on AIDS of the World Health Organization in Geneva from 1992 to 1995. From 2002-2004 he was President of the International AIDS Society.
Powered by NewsLook.com

Related Stories


Share This



Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins